photo of

Details

Role Clinical Geneticist
Group Clinical Services
Professor Martin Delatycki is a co-director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute (MCRI) and a clinical geneticist at the Victorian Clinical Genetics Services (VCGS). Martin studied medicine at the University of Melbourne and trained in paediatrics at The Royal Children’s Hospital (RCH).

Martin subsequently trained in Clinical Genetics at VCGS and then obtained his PhD for work on Friedreich ataxia through the MCRI. His research and clinical interests are neurogenetics and community genetics. Martin has over 250 publications and has obtained over $5 million in research funding.
Professor Martin Delatycki is a co-director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute (MCRI) and a clinical geneticist at the Victorian Clinical Genetics Services (VCGS). Martin studied medicine at the University of...
Professor Martin Delatycki is a co-director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute (MCRI) and a clinical geneticist at the Victorian Clinical Genetics Services (VCGS). Martin studied medicine at the University of Melbourne and trained in paediatrics at The Royal Children’s Hospital (RCH).

Martin subsequently trained in Clinical Genetics at VCGS and then obtained his PhD for work on Friedreich ataxia through the MCRI. His research and clinical interests are neurogenetics and community genetics. Martin has over 250 publications and has obtained over $5 million in research funding.

Top Publications

  • Wallis, MJ, Boys, A, Tassano, E, Delatycki, MB. Small interstitial 9p24.3 deletions principally involving KANK1 are likely benign copy number variants.. Eur J Med Genet 63(1) : 103618 2020
    view publication
  • Lynch, DR, Chin, MP, Delatycki, M, Subramony, SH, Hoyle, JC, Boesch, S, Nachbauer, W, Mariotti, C, Mathews, KD, Giunti, P, et al. Safety and Efficacy of Omaveloxolone in Friedreich's Ataxia (MOXIe Study): A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial. 2020
    view publication
  • Tan, TY, Lunke, S, Chong, B, Phelan, D, Fanjul-Fernandez, M, Marum, JE, Kumar, VS, Stark, Z, Yeung, A, Brown, NJ, et al. A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis.. Eur J Hum Genet 27(12) : 1791 -1799 2019
    view publication
  • Rummey, C, Corben, LA, Delatycki, MB, Subramony, SH, Bushara, K, Gomez, CM, Hoyle, JC, Yoon, G, Ravina, B, Mathews, KD, et al. Psychometric properties of the Friedreich Ataxia Rating Scale.. Neurol Genet 5(6) : 371 2019
    view publication
  • Delatycki, MB, Bidichandani, SI. Friedreich ataxia- pathogenesis and implications for therapies.. Neurobiol Dis 132: 104606 2019
    view publication